Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001288123-10-000071)

Filing Details

Accession Number:: 0001288123-10-000071
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-10-28 14:44:38
Reporting Period:: 2010-10-26

Filing Date:: 2010-10-28
Accepted Time:: 2010-10-28 14:44:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1098972	Antigenics Inc	AGEN	Biological Products, (No Disgnostic Substances) (2836)	061562417

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1288123	M Christine Klaskin	162 Fifth Ave., Suite 900 New York NY 10010	Vp, Finance	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-10-26	2,500	$0.98	73,956	No	4	A	Direct
Common Stock	Disposition	2010-10-26	2,500	$0.97	71,456	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	195	Indirect	by husband

Footnotes

Represents settlement of restricted stock awarded January 26, 2010.
Represents the sale of shares obtained from the vesting of the restricted stock awarded on January 26, 2010. This sale has been made through a Rule 10b5-1 trading plan.